Public-registry site landscape for NCT04996875, a Advanced Systemic Mastocytosis (AdvSM) study sponsored by Cogent Biosciences, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04996875 (registry record) |
| Sponsor | Cogent Biosciences, Inc. |
| Condition(s) | Advanced Systemic Mastocytosis (AdvSM); SM With an Associated Hematologic Neoplasm (SM-AHN); Mast Cell Leukemia (MCL); Aggressive Systemic Mastocytosis (ASM) |
| Phase | PHASE2 |
| Listed sites | 42 |
| Site countries | United States, Australia, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, Norway, Poland, Spain |
Eichor generates a preliminary site-risk snapshot for NCT04996875 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →